Ahmedabad (Gujarat):India's AYUSH and nutraceutical sectors are expected to see a significant boost following the reduction in US tariffs under the India-US Interim Trade Deal, Founder & Director of Pharmanza Herbal Pvt Ltd, Lal Hingorani, said in an exclusive conversation with ANI.

Commenting on the development, Hingorani said the industry had been under severe pressure due to high tariffs and low operating margins. "People were waiting for this change.

Our industry, particularly the AYUSH and nutraceutical sectors, was affected because it is very small and margins are limited. A 50 per cent tariff was hitting us really hard," he said. He added that the reduction in tariffs to 18 per cent would bring immediate relief to exporters.

"With the reduction to 18 per cent, we will see a significant benefit, but we still expect it to return to the normal level that existed before," Hingorani noted.

Highlighting sector-specific challenges, he pointed out that pricing pressures remain a key concern. "One factor specific to our industry is pricing.

Buyers were demanding very low prices, but given the FDA regulations and other requirements, it is simply not possible to manufacture goods at those prices," he said.

AYUSH encompasses traditional systems of medicine such as Ayurveda, Yoga, Unani, Siddha, and Homeopathy.

Source:Ndtv